ATC Group: S01BA05 Triamcinolone

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of S01BA05 in the ATC hierarchy

Level Code Title
1 S Sensory organs
2 S01 Ophthalmologicals
3 S01B Antiinflammatory agents
4 S01BA Corticosteroids, plain
5 S01BA05 Triamcinolone

Active ingredients in S01BA05

Active Ingredient Description
Triamcinolone

Triamcinolone acetonide is a more potent derivative of triamcinolone and is approximately 8 times more potent than prednisone. Although the precise mechanism of corticosteroid anti-allergic action is unknown, corticosteroids are very effective in the treatment of allergic diseases in man. Also, local injections are thought to have an anti-inflammatory effect.

Medicines in this ATC group

United States (US)

Australia (AU)

Canada (CA)

Finland (FI)

France (FR)

Lithuania (LT)

Netherlands (NL)

New Zealand (NZ)

Spain (ES)

Tunisia (TN)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.